INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO)

CUSIP: 45773H409

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
66,777,963
Total 13F shares
13,346,624
Share change
+4,673,304
Total reported value
$24,424,740
Put/Call ratio
23%
Price per share
$1.83
Number of holders
100
Value change
+$7,463,553
Number of buys
54
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
2.8%
1,885,595
$10,898,739 30 Sep 2024
13F
Deep Track Capital, LP
13F
Company
2.7%
1,804,366
$10,429,235 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
2.7%
1,797,960
$10,392,209 30 Sep 2024
13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13D/G
9.2%
3,633,333
$6,794,333 $0 31 Dec 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.93%
621,631
$3,593,609 30 Sep 2024
13F
STATE STREET CORP
13F
Company
0.73%
490,662
$2,836,026 30 Sep 2024
13F
Jong Joseph Kim
3/4/5
Chief Executive Officer, Director
mixed-class rows
3,113,086
mixed-class rows
$2,451,149 11 Mar 2022
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.5%
331,066
$1,913,561 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.31%
205,788
$1,189,455 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.2%
130,510
$754,474 30 Sep 2024
13F
GMT CAPITAL CORP
13F
Company
0.19%
126,121
$728,979 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.14%
95,132
$549,863 30 Sep 2024
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.11%
76,523
$442,303 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.11%
73,190
$423,038 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.11%
71,066
$410,761 30 Sep 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.1%
65,633
$379,359 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.09%
61,213
$353,811 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.08%
56,466
$326,374 30 Sep 2024
13F
Squarepoint Ops LLC
13F
Company
0.08%
51,528
$297,832 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.07%
46,491
$268,718 30 Sep 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.06%
40,824
$235,963 30 Sep 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.06%
38,026
$219,782 30 Sep 2024
13F
BARCLAYS PLC
13F
Company
0.05%
34,003
$196,537 30 Sep 2024
13F
Green Alpha Advisors, LLC
13F
Company
0.05%
32,214
$186,197 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.05%
30,222
$174,683 30 Sep 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.05%
30,071
$173,810 30 Sep 2024
13F
FMR LLC
13F
Company
0.04%
27,261
$157,568 30 Sep 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.03%
23,195
$134,067 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.03%
20,652
$120,000 30 Sep 2024
13F
CITIGROUP INC
13F
Company
0.03%
18,926
$109,392 30 Sep 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.03%
18,192
$105,149 30 Sep 2024
13F
Atom Investors LP
13F
Company
0.03%
17,747
$102,578 30 Sep 2024
13F
GROUP ONE TRADING LLC
13F
Company
0.03%
16,910
$97,740 30 Sep 2024
13F
MetLife Investment Management, LLC
13F
Company
0.02%
15,167
$87,665 30 Sep 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.02%
14,387
$83,157 30 Sep 2024
13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
13F
Company
0.02%
13,950
$80,631 30 Sep 2024
13F
Corebridge Financial, Inc.
13F
Company
0.02%
13,890
$80,284 30 Sep 2024
13F
UBS Group AG
13F
Company
0.02%
13,715
$79,272 30 Sep 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
13,450
$77,741 30 Sep 2024
13F
WOLVERINE TRADING, LLC
13F
Company
0.02%
12,161
$71,263 30 Sep 2024
13F
SG Americas Securities, LLC
13F
Company
0.02%
12,286
$71,000 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
11,754
$67,938 30 Sep 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.02%
11,689
$67,562 30 Sep 2024
13F
Invesco Ltd.
13F
Company
0.02%
11,013
$63,655 30 Sep 2024
13F
SIGNATURE ESTATE & INVESTMENT ADVISORS LLC
13F
Company
0.02%
10,876
$62,863 30 Sep 2024
13F
Pathstone Holdings, LLC
13F
Company
0.02%
10,266
$59,337 30 Sep 2024
13F
Keystone Financial Group
13F
Company
0.02%
10,073
$58,224 30 Sep 2024
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
9,800
$56,056 30 Sep 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.01%
9,671
$55,000 30 Sep 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.01%
5,681
$32,836 30 Sep 2024
13F

Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) as of Q4 2024

As of 31 Dec 2024, INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) was held by 100 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,346,624 shares. The largest 10 holders included Deep Track Capital, LP, BlackRock, Inc., VANGUARD GROUP INC, Stonepine Capital Management, LLC, AIGH Capital Management LLC, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, and GOLDMAN SACHS GROUP INC. This page lists 100 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
95
Q4 2024 holders
100
Holder diff
5
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.